A gas chromatographic method using a packed column and 1-eicosanol as an internal standard was developed and validated for determination of the aliphatic fatty alcohols that compose policosanol in 5 mg film-coated tablets. The alcohols were analyzed as trimethylsilyl (TMS) derivatives, prepared with N-methyl-N-trimethylsilyltrifluoroacetamide. The method can detect degradation products with high retention times without interfering with the peaks of the active principle. Good linearity (correlation coefficient = 0.9996) and accuracy (recovery = 100.44%) were proven over a range of 50-150% of the nominal concentration. Within-day and between-day precisions at the nominal 100% value met the acceptance criteria (<2%). Ruggedness was examined through an intralaboratory experimental study in which 7 operational changes were made and the observed results were quantitation, repeatability, resolution, and relative retention time. Among these results, only the relative retention time (t C28,C20 ) was significantly affected when the column used was 2.1 m instead of 3.1 m. Repeatability and reproducibility (r = 0.1506 and R = 0.2450, respectively) were obtained from a uniform-level interlaboratory test. The method is suitable for quality control and stability studies of these tablets. P olicosanol is a new cholesterol-lowering drug isolated and purified from sugar cane (Saccharum officinarum L.) wax. Its hypocholesterolemic effect has been demonstrated in experimental models (1, 2), healthy volunteers (3), and patients with type II hypercholesterolemia (4-6). This product is a mixture of 8 long-chain primary aliphatic alcohols (C 24 -C 34 ), in which 1-octacosanol is the major component (7). In a previous work (8), we developed a gas chromatographic (GC) method using a packed column for determination of the fatty alcohols that compose policosanol in film-coated tablets.
P
olicosanol is a new cholesterol-lowering drug isolated and purified from sugar cane (Saccharum officinarum L.) wax. Its hypocholesterolemic effect has been demonstrated in experimental models (1, 2) , healthy volunteers (3), and patients with type II hypercholesterolemia (4) (5) (6) . This product is a mixture of 8 long-chain primary aliphatic alcohols (C 24 -C 34 ), in which 1-octacosanol is the major component (7) . In a previous work (8) , we developed a gas chromatographic (GC) method using a packed column for determination of the fatty alcohols that compose policosanol in film-coated tablets.
In the present work, we validated an economical and less time-consuming new version of this method.
Experimental
Apparatus (a) Gas chromatograph.-Shimadzu GC 14B, interfaced with a Shimadzu C-R4A computerized data processor, or equivalent, equipped with a flame ionization detector (Shimadzu, Kyoto, Japan). GC conditions: 3 mm (id) × 3.1 m glass column, packed with 3% OV-101 on 80-100 mesh Chromosorb W (HP) (Supelco, Bellefonte, PA). Injector and detector temperatures, 320°C, column programmed from 250E to 320°C at 10°C/min and maintained isothermal for 20 min at 320°C; argon carrier gas flow, ca 35 mL/min.
(b) Gas chromatograph-mass spectrometer.-Fison Instruments (Manchester, England) GC 8000 Series MD-800, coupled to a computerized data processor, or equivalent, equipped with a capillary column SPB-5, 0.32 mm id × 25 m. Operating conditions: column programmed from 100°to 200°C at 40°C/min, and from 200°to 320°C at 8°C/min and then maintained isothermal for 90 min at 320°C; helium carrier gas flow, ca 1 mL/min. Injector, separator, and ion source temperatures were fixed at 320°, 200°, and 250°C, respectively. Electron energy was 70 eV.
Chemicals
All chemicals were analytical reagent grade: N-methyl-N-trimethylsilyltrifluoroacetamide (MSTFA; Fluka, Buchs, Switzerland, or equivalent), CHCl 3 , HCl (0.1 mol/L), H 2 O 2 (30%), and NaOH (0.1 mol/L; Merck, Darmstad, Germany, or equivalent) were used.
To prepare the internal standard solution, 0.4 mg 1-eicosanol/mL, accurately weigh 100 mg 1-eicosanol (Janssen Chimica, Geel, Belgium, or equivalent) into a 250 mL volumetric flask. Dilute to volume with CHCl 3 and mix.
To prepare the stock solution, accurately weigh 10 mg 1-tetracosanol (0.04 mg/mL), 18 mg 1-hexacosanol (0.07 mg/mL), 10 mg 1-heptacosanol (0.04 mg/mL), 182 mg 1-octacosanol (0.73 mg/mL), and 35 mg 1-triacontanol (0.14 mg/mL; Janssen Chimica, or equivalent) into a 250 mL volumetric flask. Dilute to volume with CHCl 3 and mix.
To prepare the working standard solution of policosanol (1.25 mg/mL), accurately weigh 125 mg policosanol (DALMER S.A. Laboratories, Havana, Cuba; batch No. 294) into a 100 mL volumetric flask. Dilute to volume with CHCl 3 and mix.
Tablet Formulation
The test procedure was applied to a commercial formulation of policosanol in film-coated tablets, consisting of 5 mg policosanol, lactose, sucrose, gelatin, cornstarch, special talc for tablets, microcrystalline cellulose, magnesium stearate, and sodium croscarmelose as excipients. Tablets were coated with a mixture of cellulose acetophthalate, polyethylene glycol 20000, special talc for tablets, titanium dioxide, and FD&C blue No. 2 lake (indigotine). The tablet mass was ca 120 mg.
Test Procedure
Twenty tablets were randomly selected and weighed. The average mass was calculated, and then the tablets were crushed to a fine powder. A mass equivalent to that of one tablet was transferred quantitatively to a 10 mL test tube with screw cap. Internal standard solution (3 mL) was added, and the tube was heated at 60°C for 10 min with occasional shaking. The hot solution was filtered (Whatman No. 1 filter paper; Maidstone, UK), and 0.5 mL of the filtrate was transferred to another tube. MSTFA (0.05 mL) was added, the tube was heated for 15 min at 60°C, and 2 µL portions were examined by GC.
The mass of each alcohol was obtained by the internal standard method (9) Because commercial standards of 1-nonacosanol, 1-dotriacontanol, and 1-tetratriacontanol were not available, the relative response factor of 1-octacosanol was used for 1-nonacosanol, and for the other alcohols, the relative mass response factor of 1-triacontanol was used. The total mass of policosanol was determined by adding the masses of all the alcohols. This value was corrected by taking into account sample mass and tablet average mass.
Method Validation
To enable formation of degradation products, the tablets were crushed to a fine powder and subjected to thermolysis (55°C, 9 months), base and acid hydrolysis (sample suspended in 0.1 mol NaOH/L and 0.1 mol HCl/L, respectively, at ca 1 g in 10 mL, at 108°C, 1 day), oxidation (sample suspended in 30% H 2 O 2 , at ca 1 g in 10 mL, at 25°C, 1 week), and photolysis (254 nm UV light, at 25°C, 1 week). These tests were performed in neutral glass ampoules, which were flushed with nitrogen and sealed (n = 3). Specificity of the chromatographic system was proven by comparing chromatograms of the placebo, the internal standard solution, the working standard solution of policosanol, the original tablets, and the tablets stressed under degradation conditions. Peak purity was checked by gas chromatography/mass spectrometry (GC/MS) analysis.
Linearity and accuracy were assessed over the range 50-150% of the nominal concentration. The matrix (120 mg placebo) was spiked with 2, 3, 4, 5, and 6 mL of the working standard solution. Samples were evaporated to dryness, and Recovery, % = amount found amount added × 100
Average recovery was checked to 100% with the Student t test. The experimental value of t was calculated as follows: t = 100− recovery n
RSD
The null hypothesis (the recovery is close to 100% and the method is accurate) was accepted for a significance level greater than 5%.
Within-day and between-day precisions were evaluated by assaying commercial tablets in 2 different laboratories by the current method. One laboratory also assayed a sample of spiked placebos and further assayed tablets by a previously reported method (8): A mass of powder equivalent to that of a tablet was transferred quantitatively to a round-bottom flask; 1,2-dichloroethane (20 mL) and a solution of 1-eicosanol (1 mg/mL) in 1,2-dichloroethane (0.5 mL) were added; the mixture was heated to reflux for 20 min; the hot solution was filtered (Whatman No. 1 filter paper); the filtrate, collected in another round-bottom flask, was evaporated to dryness; MSTFA (0.1 mL) and CHCl 3 (1 mL) were added; and this mixture was heated at 60°C for 15 min. Portions (2 µL) were analyzed by GC. Each operator followed the procedure under conditions of repeatability (n = 8). Fisher (F) and Student (t) tests for p = 0.05 were performed to determine significant differences between results. Ruggedness was evaluated by an intralaboratory experimental study in which the influence of small changes in the operating conditions on results was evaluated. Seven variables were studied by performing 8 separate experiments (n = 6) as described by Youden (10) . The selected factors and levels are shown in Table 1 . The observed results were amount of policosanol (P), precision (SD), resolution between alcohols C 28 and C 30 (Rs C28-C30 ), and relative retention for alcohol C 28 (t C28,C20 ).
Precision was also determined from a uniform-level interlaboratory test involving 9 laboratories. Participants were requested to perform 3 replicates under repeatability conditions. Statistical analyses were performed according to the guidelines in ISO 5725.
Results and Discussion
The analytical procedure allows rapid, reliable, and reproducible determination of the mixture of long-chain primary aliphatic alcohols identified as policosanol. The specificity assay showed that degradation occurred only when tablets are subjected to thermolysis. The method detects degradation products (octacosanyl stearate and palmitate; 11) at high retention times (55 and 75 min), without interfering with the determination of policosanol. Figure 1 shows that the chromatographic conditions gives well-resolved peaks corresponding to samples of placebo, 1-eicosanol, and policosanol. No difference between the partial chromatogram of degraded tablets and the chromatogram of tablets containing 5 mg policosanol can be seen in Figure 2 . The peaks corresponding to degradation products are not shown because they elute at high retention times.
Linearity and Accuracy
The calculated regression line was y = (1.0035 ± 0.0075)x + (0.0033 ± 0.0400), with CI calculated at p = 0.05. The correlation coefficient was 0.9996. Because use of the correlation coefficient is not always sufficient to assess linearity, RSD f (0.92%) and RSD b (0.75%) were calculated. The CI (0.003 ± 0.086) includes the zero value; thus it can be concluded that the line passes through the origin. The procedure could be considered linear and proportional in the concentration range studied.
Recoveries from spiked placebos were 99.15-100.98% of the expected amounts, with RSD values <2% ( Table 2 ). These high recoveries were made possible by the addition of an internal standard at the beginning of extraction. The average recovery and 100% of recovery were not significantly different according to the calculated t (1.850), which was lower than the critical value for p = 0.05.
Repeatability
The method performed well in the initial precision study with real tablets by 2 laboratories (Table 3) . No significant variations between the 2 series of analysis (F calc = 1.45 and t calc = 0.613) were found through the F and t tests. Within-day RSD values were <2% in both cases and between-day RSD (n = 16) was 1.32%. Confidence limits were 4.93 ± 0.04 mg; therefore in 95 of 100 cases, the real value will lie within the range 4.89-4.97 mg. Real tablets and spiked placebos were analyzed to evaluate matrix interference effects. The amount of policosanol per tablet was 98.80% (4.94 mg) of the declared dose, and the recovery from spiked placebos was 99.60% (4.98 mg) of the added amount (Table 3) . These results are very similar, and the calculated values for F and t (1.467 and 1.192, respectively) are less than the critical values for p = 0.05. Therefore, the mixing of active ingredients and excipients does not affect recovery.
Finally, statistical analyses (experimental F and t values 1.306 and 2.128, respectively) show no significant difference in either the precision or the means obtained from the 2 sample preparation methods.
Ruggedness
The means of results for each experiment (Table 4) , the effects on the observed results, and the limit values of these effects as expressed by %2 SD (Table 5) were calculated. Only the t C28,C20 was significantly affected when the column used was 2.1 m. No significant effect was observed on other results.
Interlaboratory Assay
Results of the interlaboratory assay are presented in Table 6. According to the Cochran test, there are no outliers in this table, but according to Grubb's test, one collaborator deviated from the procedure. For subsequent analyses, all values were considered. Method precision was good, as demonstrated by the following statistical data for repeatability: r = 0.1506, S r = 0.053, and RSD r = 1.13%; and for reproducibility: R = 0.2450, S R = 0.087, and RSD R = 1.85%.
